The Sequelae of Tuberculous Meningitis

Todd, R. McLaren; Neville, Joseph G.

doi:10.1136/adc.39.205.213

Cited by 39 publications

(16 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…TBM related stroke most commonly manifests with focal weakness such as monoplegia, hemiplegia or quadriplegia [26,75]. The other neurological manifestations of stroke such as sensory impairment, ataxia, seizures, movement disorders, cranial nerve palsy, aphasia, apraxia and hypothalamic disturbances depend on the location of infarctions.…”

Section: Clinical Features Of Stroke In Tuberculous Meningitismentioning

confidence: 99%

Stroke in tuberculous meningitis

Misra

Maurya

2011

Journal of the Neurological Sciences

164

152

View full text Add to dashboard Cite

Section: Clinical Features Of Stroke In Tuberculous Meningitismentioning

confidence: 99%

Stroke in tuberculous meningitis

Misra

Maurya

2011

Journal of the Neurological Sciences

164

152

View full text Add to dashboard Cite

“…Epilepsy occurs in 8–14% of patients following tuberculous meningitis 16. This compares with a 2.4% risk following pyogenic meningitis without acute seizures, and 13% risk if complicated acutely by seizures 17.…”

Section: What Is Known About Epilepsy In Sub-saharan Africa?mentioning

confidence: 99%

Epilepsy in sub-Saharan Africa

Prevett

2013

Pract Neurol

View full text Add to dashboard Cite

Over 10 million people in Africa have epilepsy of which most have no access to appropriate treatment. Epilepsy in Africa is different- the incidence is higher, and the causes and cultural attitudes towards it differ. This article examines the epidemiology, causes and treatment of epilepsy in sub-Saharan Africa and looks at the challenges to improve access to treatment and potential solutions and the implications for neurologists in more developed countries.

show abstract

“…Lorber also found that the incidence of calcification was a little less in patients who were treated with isoniazid and streptomycin than in those with streptomycin alone or with streptomycin plus P.A.S., but this was not verified by others (Todd and Neville, 1964). The use of adjuvants-for example, streptokinase BRITISH MEDICAI JOURNAL -also seemed to reduce the incidence of meningeal calcificatiort in selected groups.…”

Section: Calcificationmentioning

confidence: 95%